Key facts
- This page summarizes Orlov S. Nicole Schaeffer's Form 4 filing for INSMED Inc (INSM).
- 9 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 06 Jan 2026, 16:03.
Orlov S. Nicole Schaeffer - 02 Jan 2026 Form 4 Insider Report for INSMED Inc (INSM)
- Reporting relationship
- Chief People Strategy Officer
- Issuer ticker
- INSM
- Reported as of
- 02 Jan 2026
- Net transaction value
- -$14,079,218
- SEC form
- 4
- Accepted by SEC
- 06 Jan 2026, 16:03:21 UTC
- Prior SEC filing
- 14 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ S. Nicole Schaeffer, by Michael A. Smith as Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Orlov S. Nicole Schaeffer filed Form 4 for INSMED Inc (INSM) on 06 Jan 2026.
Change
- Previous filing in this sequence was filed on 14 Nov 2025.
- Current net transaction value: -$14,079,218.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001401017
Primary reporting owner
Schaeffer Orlov S Nicole
- Relationship
- Chief People Strategy Officer
- Address
- 700 US HIGHWAY 202/206, BRIDGEWATER
- Signature
- /s/ S. Nicole Schaeffer, by Michael A. Smith as Attorney-in-fact
- Signature date
- 06 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INSM
transaction
Common Stock
Award
- Transaction value
- Shares
- +5,293
- Change %
- +15%
- Price
- Shares after
- 41,754
- Date
- 02 Jan 2026
- Ownership
- Direct
- Footnotes
- F1, F2
INSM
transaction
Common Stock
Options Exercise
- Transaction value
- $1,214,204
- Shares
- +87,290
- Change %
- +209%
- Price
- $13.91
- Shares after
- 129,044
- Date
- 02 Jan 2026
- Ownership
- Direct
- Footnotes
- F3
INSM
transaction
Common Stock
Sale
- Transaction value
- $5,407,908
- Shares
- -31,030
- Change %
- -24%
- Price
- $174.28
- Shares after
- 98,014
- Date
- 02 Jan 2026
- Ownership
- Direct
- Footnotes
- F3, F4
INSM
transaction
Common Stock
Sale
- Transaction value
- $5,973,823
- Shares
- -34,103
- Change %
- -35%
- Price
- $175.17
- Shares after
- 63,911
- Date
- 02 Jan 2026
- Ownership
- Direct
- Footnotes
- F3, F5
INSM
transaction
Common Stock
Sale
- Transaction value
- $2,259,459
- Shares
- -12,832
- Change %
- -20%
- Price
- $176.08
- Shares after
- 51,079
- Date
- 02 Jan 2026
- Ownership
- Direct
- Footnotes
- F3, F6
INSM
transaction
Common Stock
Sale
- Transaction value
- $1,616,676
- Shares
- -9,125
- Change %
- -18%
- Price
- $177.17
- Shares after
- 41,954
- Date
- 02 Jan 2026
- Ownership
- Direct
- Footnotes
- F3, F7
INSM
transaction
Common Stock
Sale
- Transaction value
- $35,556
- Shares
- -200
- Change %
- -0.48%
- Price
- $177.78
- Shares after
- 41,754
- Date
- 02 Jan 2026
- Ownership
- Direct
- Footnotes
- F3, F8
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INSM
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +27,600
- Change %
- Price
- $0.000000
- Shares after
- 27,600
- Date
- 02 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 27,600
- Exercise price
- $177.12
- Footnotes
- F9
INSM
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -87,290
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 02 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 87,290
- Exercise price
- $13.91
- Footnotes
- F3, F10
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 10 footnotes
Footnote F1
Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
Footnote F2
Each RSU was granted on January 2, 2026 for no consideration.
Footnote F3
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Footnote F4
This is the weighted average sales price representing 31,030 shares sold at prices ranging from $173.67 to $174.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Footnote F5
This is the weighted average sales price representing 34,103 shares sold at prices ranging from $174.67 to $175.65 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Footnote F6
This is the weighted average sales price representing 12,832 shares sold at prices ranging from $175.67 to $176.62 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Footnote F7
This is the weighted average sales price representing 9,125 shares sold at prices ranging from $176.68 to $177.67 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Footnote F8
This is the weighted average sales price representing 200 shares sold at prices ranging from $177.72 to $177.84 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Footnote F9
These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.
Footnote F10
The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.